Tel: 03 21 79 17 51
Dr. Maxime Culot is presently associate professor at the Faculty of Sciences, University of Artois, Lens, France, where he received his Ph.D. in 2007. During his thesis He participates in a research program with AstraZeneca aimed at both identifying molecular mechanisms underlying BBB dysfunction in stroke and investigating neurovascular protective actions of various compounds through the use of different in vitro BBB models, proteomics and cells from knock-out animals. He was also involved in the development of a new in vitro model of the BBB adapted to the screening of large number of compounds and contributed to several research contracts with pharmaceutical compagnies. In his actual position he is responsible for pharmaceutical and toxicological applications of cell and tissue culture to CNS drug distribution and his current research focuses on macromolecular transport processes across the BBB.